ShockWave Medical, Inc.
SWAV · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $6,994,707 | $7,381,551 | $6,259,050 | $3,431,897 |
| - Cash | $328,422 | $156,586 | $89,209 | $50,423 |
| + Debt | $770,607 | $60,404 | $47,189 | $24,980 |
| Enterprise Value | $7,436,892 | $7,285,369 | $6,217,030 | $3,406,454 |
| Revenue | $730,230 | $489,733 | $237,146 | $67,789 |
| % Growth | 49.1% | 106.5% | 249.8% | – |
| Gross Profit | $634,842 | $424,737 | $195,708 | $46,798 |
| % Margin | 86.9% | 86.7% | 82.5% | 69% |
| EBITDA | $190,834 | $127,570 | -$871 | -$63,151 |
| % Margin | 26.1% | 26% | -0.4% | -93.2% |
| Net Income | $147,278 | $215,996 | -$9,136 | -$65,699 |
| % Margin | 20.2% | 44.1% | -3.9% | -96.9% |
| EPS Diluted | 3.85 | 5.7 | -0.26 | -1.99 |
| % Growth | -32.5% | 2,292.3% | 86.9% | – |
| Operating Cash Flow | $196,053 | $117,732 | $15,036 | -$71,184 |
| Capital Expenditures | -$30,595 | -$25,126 | -$12,439 | -$11,520 |
| Free Cash Flow | $165,458 | $92,606 | $2,597 | -$82,704 |